Simulation approach for assessing the performance of the γEWMA control chart

i) Purpose: The purpose of this paper is to evaluate the performance of a modified EWMA control chart ($\gamma$EWMA control chart), which considers data distribution and incorporate its correlation structure, simulating in-control and out-of-control processes and to select an adequate value for smoothing parameter with these conditions. ii) Design/methodology/approach: This paper is based on a simulation approach using the methodology for evaluating statistical methods proposed by Morris et al. (2019). Data were generated from a simulation considering two factors that associated with data: (1) quality variable distribution skewness as an indicator of quality variable distribution; (2) the autocorrelation structure for type of relationship between the observations and modeled by AR(1). In addition, one factor associated with the process was considered, (1) the shift in the process mean. In the following step, when the chart control is modeled, the fourth factor intervenes. This factor is a smoothing parameter. Finally, three indicators defined from the Run Length are used to evaluate γEWMA control chart performance this factors and their interactions. iii) Findings: Interaction analysis for four factor evidence that the modeling and selection of parameters is different for out-of-control and in-control processes therefore the considerations and parameters selected for each case must be carefully analyzed. For out-of-control processes, it is better to preserve the original features of the distribution (mean and variance) for the calculation of the control limits. It makes sense that highly autocorrelated observations require smaller smoothing parameter since the correlation structure enables the preservation of relevant information in past data. iv) Originality/value: The $\gamma$EWMA control chart there has advantages because it gathers, in single chart control: the process and modelling characteristics, and data structure process. Although there are other proposals for modified EWMA, none of them simultaneously analyze the four factors nor their interactions. The proposed $\gamma$EWMA allows setting the appropriate smoothing parameter when these three factors are considered

Ancient mitochondrial pseudogenes reveal hybridization between distant lineages in the evolution of the Rupicapra genus

© The Author(s), 2017. This is the author's version of the work and is distributed under the terms of the Creative Commons Attribution License. The definitive version was published in Gene 628 (2017): 63-71, doi:10.1016/j.gene.2017.07.035.Mitochondrial pseudogenes (numts) inserted in the nuclear genome are frequently found in population studies. Its presence is commonly connected with problems and errors when they are confounded with true mitochondrial sequences. In the opposite side, numts can provide valuable phylogenetic information when they are copies of ancient mitochondrial lineages. We show that Rupicapra individuals of different geographic origin from the Cantabrian Mountains to the Apennines and the Caucasus share a nuclear COI fragment. The numt copies are monophyletic, and their pattern of differentiation shows two outstanding features: a long evolution as differentiated true mitochondrial lineage, and a recent integration and spread through the chamois populations. The COI pseudogene is much older than the present day mitochondrial clades of Rupicapra and occupies a basal position within the Rupicapra-Ammotragus- Arabitragus node. Joint analysis of this numt and a cytb pseudogene with a similar pattern of evolution places the source mitochondrial lineage as a sister branch that separated from the Ammotragus-Arabitragus lineage 6 million years ago (Mya). The occurrence of this sequence in the nucleus of chamois suggests hybridization between highly divergent lineages. The integration event seems to be very recent, more recent than the split of the present day mtDNA lineages of Rupicapra (1.9 Mya). This observation invites to think of the spread across the genus by horizontal transfer through recent male-biased dispersal.This work was funded by Ministerio de Economía y Competitividad. Spain. (Grant number CGL2011-25117).2018-07-1

Inspección de subestaciones eléctricas: YOLOv5 en la identificación de puntos calientes mediante imágenes térmicas

Substations are key facilities within an electrical system, untimely failures tend to cause low quality and negative effects on the electrical supply. An early indicator of potential electrical equipment failure is the appearance of hot spots; therefore, its detection and subsequent programmed correction avoids incurring in major failures and unnecessary operation stops. In this research, 64 experiments of the YOLOv5 algorithm were carried out, with the purpose of proposing an automated computer vision mechanism for the detection of hot spots in thermal images of electrical substations. The best results show a mAP value of 81.99%, which were obtained with the YOLOv5m algorithm and the transfer learning application. These results leave a basis to deepen and improve the performance of the algorithm by varying other hyperparameters to those considered in this study.Las subestaciones son instalaciones clave dentro de un sistema eléctrico; las fallas intempestivas tienden a causar baja calidad y efectos negativos del suministro eléctrico. Un indicador temprano de posibles fallas en los equipos eléctricos es la aparición de puntos calientes; por lo que su detección y posterior corrección programada evita incurrir en fallas mayores y paradas de operación innecesarias. En esta investigación se realizaron 64 experimentos del algoritmo YOLOv5, con la finalidad de proponer un mecanismo automatizado de visión por computadora para la detección de puntos calientes en imágenes térmicas de subestaciones eléctricas. Los mejores resultados muestran un valor mAP de 81,99 %, los cuales se obtuvieron con el algoritmo YOLOv5m y la aplicación de transfer learning. Estos resultados dejan una base para profundizar y mejorar el desempeño del algoritmo, variando otros hiperparámetros a los considerados en el presente estudio

A Comprehensive Study on Pain Assessment from Multimodal Sensor Data

Pain assessment is a critical aspect of healthcare, influencing timely interventions and patient well-being. Traditional pain evaluation methods often rely on subjective patient reports, leading to inaccuracies and disparities in treatment, especially for patients who present difficulties to communicate due to cognitive impairments. Our contributions are three-fold. Firstly, we analyze the correlations of the data extracted from biomedical sensors. Then, we use state-of-the-art computer vision techniques to analyze videos focusing on the facial expressions of the patients, both per-frame and using the temporal context. We compare them and provide a baseline for pain assessment methods using two popular benchmarks: UNBC-McMaster Shoulder Pain Expression Archive Database and BioVid Heat Pain Database. We achieved an accuracy of over 96% and over 94% for the F1 Score, recall and precision metrics in pain estimation using single frames with the UNBC-McMaster dataset, employing state-of-the-art computer vision techniques such as Transformer-based architectures for vision tasks. In addition, from the conclusions drawn from the study, future lines of work in this area are discussed

A DNA vaccine encoding foot-and-mouth disease virus B and T-cell epitopes targeted to class II swine leukocyte antigens protects pigs against viral challenge

Development of efficient and safer vaccines against foot-and-mouth disease virus (FMDV) is a must. Previous results obtained in our laboratory have demonstrated that DNA vaccines encoding B and T cell epitopes from type C FMDV, efficiently controlled virus replication in mice, while they did not protect against FMDV challenge in pigs, one of the FMDV natural hosts. The main finding of this work is the ability to improve the protection afforded in swine using a new DNA-vaccine prototype (pCMV-APCH1BTT), encoding FMDV B and T-cell epitopes fused to the single-chain variable fragment of the 1F12 mouse monoclonal antibody that recognizes Class-II Swine Leukocyte antigens. Half of the DNA-immunized pigs were fully protected upon viral challenge, while the remaining animals were partially protected, showing a delayed, shorter and milder disease than control pigs. Full protection in a given vaccinated-pig correlated with the induction of specific IFNγ-secreting T-cells, detectable prior to FMDV-challenge, together with a rapid development of neutralizing antibodies after viral challenge, pointing towards the relevance that both arms of the immune response can play in protection. Our results open new avenues for developing future FMDV subunit vaccines.Fil: Borrego, Belén. No especifíca;Fil: Argilaguet, Jordi M.. Universitat Autònoma de Barcelona; EspañaFil: Pérez Martín, Eva. Universitat Autònoma de Barcelona; EspañaFil: Dominguez, Javier. No especifíca;Fil: Pérez Filgueira, Daniel Mariano. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Escribano, José M.. No especifíca;Fil: Sobrino, Francisco. No especifíca;Fil: Rodriguez, Fernando. Universitat Autònoma de Barcelona; Españ

Spondyloarthropathies in Autoimmune Diseases and Vice Versa

Polyautoimmunity is one of the major clinical characteristics of autoimmune diseases (ADs). The aim of this study was to investigate the prevalence of ADs in spondyloarthropathies (SpAs) and vice versa. This was a two-phase cross-sectional study. First, we examined the presence of ADs in a cohort of patients with SpAs (N = 148). Second, we searched for the presence of SpAs in a well-defined group of patients with ADs (N = 1077) including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and Sjögren's syndrome (SS). Among patients with SpAs, ankylosing spondylitis was observed in the majority of them (55.6%). There were two patients presenting with SS in the SpA group (1.4%) and 5 patients with autoimmune thyroiditis (3.5%). The global prevalence of ADs in SpAs was 4.86%. In the ADs group, there were 5 patients with SpAs (0.46%). Our results suggest a lack of association between SpAs and ADs. Accordingly, SpAs might correspond more to autoinflammatory diseases rather than to ADs

Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (CCND1b)

Cyclin D1b is an alternative transcript of the cyclin D1 gene (CCND1) expressed in human tumors. Its abundance is regulated by a single base pair polymorphism at the exon 4/intron 4 boundary (nucleotide 870). Epidemiological studies have shown a correlation between the presence of the G870A allele (that favors the splicing for cyclin D1b) with increased risk and less favorable outcome in several forms of cancer. More recently, it has been shown that, unlike cyclin D1a, the alternative transcript D1b by itself has the capacity to transform fibroblasts in vitro. In order to study the oncogenic potential of cyclin D1b, we developed transgenic mice expressing human cyclin D1b under the control of the bovine K5 promoter (K5D1b mice). Seven founders were obtained and none of them presented any significant phenotype or developed spontaneous tumors. Interestingly, K5D1b mice do not develop the fatal thymic hyperplasia, which is characteristic of the cyclin D1a transgenic mice (K5D1a). Susceptibility to skin carcinogenesis was tested in K5D1b mice using two-stage carcinogenesis protocols. In two independent experiments, K5D1b mice developed higher papilloma multiplicity as compared with wild-type littermates. However, when K5D1b mice were crossed with cyclin D1KO mice, the expression of cyclin D1b was unable to rescue the carcinogenesis-resistant phenotype of the cyclin D1 KO mice. To further explore the role of cyclin D1b in mouse models of carcinogenesis we carried out in silico analysis and in vitro experiments to evaluate the existence of a mouse homologous of the human cyclin D1b transcript. We were unable to find any evidence of an alternatively spliced transcript in mouse Ccnd1. These results show that human cyclin D1b has different biological functions than cyclin D1a and confirm its oncogenic properties.Fil: Rojas, Paola Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina. University of Texas; Estados UnidosFil: Benavides, Fernando. University of Texas; Estados UnidosFil: Blando, Jorge. University of Texas; Estados UnidosFil: Pérez, Carlos. University of Texas; Estados UnidosFil: Cardenas, Kim. University of Texas; Estados UnidosFil: Richie, Ellen. University of Texas; Estados UnidosFil: Knudsen, Erik S.. Thomas Jefferson University; Estados UnidosFil: Johnson, David G.. University of Texas; Estados UnidosFil: Senderowicz, Adrian M.. Department of Health and Human Services. Food and Drug Administration. Center for Drug Evaluation and Research; Estados UnidosFil: Rodriguez Puebla, Marcelo L.. University of North Carolina; Estados UnidosFil: Conti, Claudio. University of Texas; Estados Unido

The anticancer effect related to disturbances in redox balance on Caco-2 cells caused by an alkynyl gold(I) complex

The alkynyl gold(I) derivative Au(C=CPh)(PTA)] (PTA = 1, 3, 5-triaza-7-phosphaadamantane) induces apoptosis in colorectal carcinoma tumour cells (Caco-2) without affecting to normal enterocytes. Au(C=CPh)(PTA)] is a slight lipophilic drug, stable in PBS (Phosphate Buffered Saline) and able to bind BSA (Bovin Serum Albumin) by hydrophobic interactions. Once inside the cell, Au(C=CPh)(PTA)] targets seleno proteins such as Thioredoxin Reductase 1, increasing ROS (Reactive Oxygen Species) levels, reducing cell viability and proliferation and inducing mitochondrial apoptotic pathway, pro-apoptotic and anti-apoptotic protein imbalance, loss of mitochondrial membrane potential, cytochrome c release and activation of caspases 9 and 3. Moreover, unlike other metal-based drugs such as cisplatin, Au(C=CPh)(PTA)] does not target nucleic acid, reducing the risk of side mutation in the DNA. In consequence, our results predict a promising future for Au(C=CPh)(PTA)] as a chemotherapeutic agent for colorectal carcinoma